Covid 19

Mucormycosis: 7.2k Indians Affected So Far; Centre, States Raise Alarm

The infection is a COVID-19 complication, that usually occurs in recovered COVID-19 patients results from indiscriminate use of steroids, according to medical experts.

As the second wave of COVID-19 is witnessing downward trends, mucormycosis, also known as black fungus has emerged as a new cause of worry in the country with 7250 cases detected so far, according to the figures shared by officials in 13 states and Union territories with Hindustan Times. The fungus infection has killed 219 people so far in India.

The infection is a Covid-19 complication, that usually occurs in recovered COVID-19 patients results from indiscriminate use of steroids, according to medical experts.

The infection is a Covid-19 complication, that usually occurs in recovered COVID-19 patients results from indiscriminate use of steroids, according to medical experts. On Thursday, the Central government said the states should declare the disease notifiable under the Epidemic Diseases Act, 1897.

Maharashtra reported the highest number of infections so far with 1,500 cases and 90 deaths due to it. State Health Minister Rajesh Tope urged the Centre on Wednesday to swiftly allocate to the state Amphotericin B injection, used to treat mucormycosis patients.

Delhi Chief Minister Arvind Kejriwal, meanwhile, has called for three government hospitals in the city – Lok Nayak, GTB and Rajeev Gandhi hospitals – to be set up dedicated centres for black fungus cases.

Also Read: ā€œI Would Rather Die In Jail, Donā€™t Want To Be Hospitalisedā€: Father Stan Swamy To Bombay HC

All India Institute of Medical Science (AIIMS) director Randeep Guleria has listed three important factors to prevent the “black fungus” outbreak.

“We have to see at prevention of this outbreak,” Guleria said, adding the three factors that are very important. “Good control of blood sugar levels, those on steroids must monitor blood sugar levels regularly, and be careful about when to give steroids and their dosage,” the AIIMS Director said.

Dear Readers,
As an independent media platform, we do not take advertisements from governments and corporate houses. It is you, our readers, who have supported us on our journey to do honest and unbiased journalism. Please contribute, so that we can continue to do the same in future.

Related posts